1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834.
  2. Zhao J, Xu L, Sun J, Song M, Wang L, Yuan S, Zhu Y. et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019: BMJ Oncology 2023;2:e000049.
  3. Brenner DR, Gillis J, Demers AA, Ellison LF, Billette JM, Zhang SX, Liu JL, Woods RR, Finley C, Fitzgerald N, Saint-Jacques N, Shack L, Turner D; Canadian Cancer Sta@s@cs Advisory Commi_ee. Projected es@mates of cancer in Canada in 2024. CMAJ. 2024 May 12;196(18):E615-E623. doi: 10.1503/cmaj.240095. Erratum in: CMAJ. 2024 Jun 2;196(21):E731. doi: 10.1503/cmaj.240712
  4. Brenner DR, Gillis JL, Demers A, Ellison LF, Bille_e JM, Zhang SX, Liu J, Woods RR, Finley C, Fitzgerald N, Saint-Jacques N, Shack L, Turner D, for the Canadian Cancer Sta@s@cs Advisory Commi_ee. Projected es@mates of cancer in Canada in 2024. CMAJ 2024; May 13;196:E615-23.
  5. Shahid K, Khalife M, Dabney R, Phan AT. Immunotherapy and targeted therapy-the new roadmap in cancer treatment. Ann Transl Med. 2019 Oct;7(20):595. doi: 10.21037/atm.2019.05.58
  6. Ratcliff C, Naik AD, Mar@n LA, Moye J. Examining cancer survivorship trajectories: Exploring the intersec@on between qualita@ve illness narra@ves and quan@ta@ve screening instruments. Palliat Support Care. 2018 Dec;16(6):712-718. doi: 10.1017/S1478951517000967.
  7. Rowland JH, Bellizzi KM. Cancer survivorship issues: life after treatment and implications for an aging population. J Clin Oncol. 2014 Aug 20;32(24):2662-8. doi: 10.1200/JCO.2014.55.8361.
  8. Gegechkori N, Haines L, Lin JJ. Long-Term and Latent Side Effects of Specific Cancer Types. Med Clin North Am. 2017 Nov;101(6):1053-1073. doi: 10.1016/j.mcna.2017.06.003. Epub 2017 Aug 2. PMID: 28992854; PMCID: PMC5777532.Late
  9. Okwuosa TM, Anzevino S, Rao R. Cardiovascular disease in cancer survivors. Postgraduate medical journal. 2017 Feb;93(1096):82–90. doi: 10.1136/postgradmedj-2016-134417
  10. Okwuosa TM, Anzevino S, Rao R. Cardiovascular disease in cancer survivors. Postgraduate medical journal. 2017 Feb;93(1096):82–90. doi: 10.1136/postgradmedj-2016-134417
  11. Or, M., Liu, B., Lam, J. et al. A systematic review and meta-analysis of treatment-related toxicities of curative and palliative radiation therapy in non-small cell lung cancer. Sci Rep 2021;11:5939. https://doi.org/10.1038/s41598-021-85131-7
  12. Tommasi C, Balsano R, Corianò M, Pellegrino B, Saba G, Bardanzellu F, Denaro N, Ramundo M, Toma I, Fusaro A, Martella S, Aiello MM, Scartozzi M, Musolino A, Solinas C. Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm? J Clin Med. 2022 Dec 6;11(23):7239. doi: 10.3390/jcm11237239. PMID: 36498813; PMCID: PMC9738151.
  13. Carlile A, McAdam T. The Long-Term and Late Effects of the Diagnosis and Treatment of Colorectal Cancer. Ulster Med J. 2023 May;92(2):98-102. Epub 2023 Aug 29. PMID: 37649914; PMCID: PMC10464626.
  14. Voskanyan V, Marzorati C, Sala D. et al. Psychosocial factors associated with quality of life in cancer survivors: umbrella review. J Cancer Res Clin Oncol. 2024;150:249. https://doi.org/10.1007/s00432-024-05749-8
  15. Recklitis CJ, Syrjala KL. Provision of integrated psychosocial services for cancer survivors post-treatment. Lancet Oncol. 2017 Jan;18(1):e39-e50. doi: 10.1016/S1470-2045(16)30659-3. PMID: 28049576; PMCID: PMC5865587.
  16. Aaronson NK, Mattioli V, Minton O, Weis J, Johansen C, Dalton SO, Verdonck-de Leeuw IM, Stein KD, Alfano CM, Mehnert A, de Boer A, van de Poll-Franse LV. Beyond treatment - Psychosocial and behavioural issues in cancer survivorship research and practice. EJC Suppl. 2014 Jun;12(1):54-64. doi: 10.1016/j.ejcsup.2014.03.005
  17. Acquati C, Miller-Sonet E, Zhang A, Ionescu E. Social Wellbeing in Cancer Survivorship: A Cross-Sectional Analysis of Self-Reported Relationship Closeness and Ambivalence from a Community Sample. Curr Oncol. 2023 Jan 31;30(2):1720-1732. doi: 10.3390/curroncol30020133.
  18. Martins H, & Caldeira S. Spiritual Distress in Cancer Patients: A Synthesis of Qualitative Studies. Religions 2018;9(10):285. https://doi.org/10.3390/rel910028
  19. Stricker CT. Survivorship Care Challenges: Navigating Changing Concerns. J Adv Pract Oncol. 2022 Apr;13(3):257-259. doi: 10.6004/jadpro.2022.13.3.15.
  20. Howell D, Harth T, Brown JA, Bennet C, Boyco S. Self-management education interventions for patients with cancer: a systematic review. Supp Care Canc. 2017;25(4):1323–55.
  21. Chen CP, Slater D. Career Counselling for Cancer Survivors Returning to Work. Canadian Journal of Career Development. 2023;22(1):19–27. https://doi.org/10.53379/cjcd.2023.348
  22. de Boer AGEM, Taskila T, Ojajärvi A, van Dijk FJH, Verbeek JHAM. Cancer Survivors and Unemployment: A Meta-analysis and Meta-regression. JAMA. 2009;301(7):753–762. doi:10.1001/jama.2009.187
  23. Ngan TT, Tien TH, Donnelly M, O’Neill C. Financial toxicity among cancer patients, survivors and their families in the United Kingdom: a scoping review, Journal of Public Healt 2023;45(4): e702–e713, https://doi.org/10.1093/pubmed/fdad143
  24. Iragorri N, de Oliveira C, Fitzgerald N, Essue B. The Out-of-Pocket Cost Burden of Cancer Care-A Systematic Literature Review. Curr Oncol. 2021 Mar 15;28(2):1216-1248. doi: 10.3390/curroncol28020117. PMID: 33804288; PMCID: PMC8025828.
  25. Mudaranthakam DP, Hughes D, Johnson P, Mason T, Nollen N, Wick J, et al. Career disruption and limitation of financial earnings due to cancer, JNCI Cancer Spectrum 2023;7(4), pkad044, https://doi.org/10.1093/jncics/pkad044
  26. Bedaso A, Dejenu G, Duko B. Depression among caregivers of cancer patients: Updated systematic review and meta-analysis. Psychooncology. 2022 Nov;31(11):1809-1820. doi: 10.1002/pon.6045. Epub 2022 Oct 17. PMID: 36209385; PMCID: PMC9828427.
  27. Florido R, Daya NR, Ndumele CE, Koton S, Russell SD, Prizment A, Blumenthal RS, Matsushita K, Mok Y, Felix AS, Coresh J, Joshu CE, Platz EA, Selvin E. Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study. J Am Coll Cardiol. 2022 Jul 5;80(1):22-32. doi: 10.1016/j.jacc.2022.04.042.
  28. Wang S, El Jurdi N, Thyagarajan B, Prizment A, Blaes AH. Accelerated Aging in Cancer Survivors: Cellular Senescence, Frailty, and Possible Opportunities for Interventions. Int J Mol Sci. 2024 Mar 14;25(6):3319. doi: 10.3390/ijms25063319.
  29. Jiang C, Deng L, Karr MA, Wen Y, Wang Q, Perimbeti S, Shapiro CL, Han X. Chronic comorbid conditions among adult cancer survivors in the United States: Results from the National Health Interview Survey, 2002-2018. Cancer. 2022 Feb 15;128(4):828-838. doi: 10.1002/cncr.33981.
  30. Harrison, S, Watson, E, Ward, A, Khan, N, Turner, D, Adams, E, Forman, D, Roche, M and Rose, P Primary health and supportive care needs of long-term cancer survivors: a questionnaire survey. Journal of Clinical Oncology, 2011;29(15):2091-2098. Doi: 10.1200/JCO.2010.32.5167.
  31. Foster C, Fenlon D. Recovery and self-management support following primary cancer treatment. Br J Cancer. 2011 Nov 8;105 Suppl 1(Suppl 1):S21-8. doi: 10.1038/bjc.2011.419. PMID: 22048029; PMCID: PMC3251956.
  32. O’Reilly S, Weadick CS, Keogh RJ. Sustainability: a multifaceted important aspect of cancer care. BJC Rep 2024;2:19. https://doi.org/10.1038/s44276-023-00025-7c
  33. Jefford M, Howell D, Qiuping L, Lisy K, Maher J, Alfano C, Rynderman M, Emery J. Improved models of care for cancer survivors. Lancet Oncology 2022;399
  34. Springer F, Mehnert-Theuerkauf A, Gebhardt C, Stolzenburg JU, Briest S. Unmet supportive care needs among cancer patients: exploring cancer entity-specific needs and associated factors. J Cancer Res Clin Oncol. 2024 Apr 12;150(4):190. doi: 10.1007/s00432-024-05715-4. PMID: 38607426; PMCID: PMC11009727.
  35. Halpern MT, McCabe MS, Burg MA. The cancer survivorship journey: models of care, disparities, barriers, and future directions. ASCO Clinical Oncology Educational Book. 2019;36: https://doi.org/10.1200/EDBK_156039
  36. Urquhart R, Cordoba W, Bender J, Cuthbert C, Easley J, Howell D, Kaal J, Kendell C, Radford S, Sussman J. Risk Stratification and Cancer Follow-Up: Towards More Personalized Post-Treatment Care in Canada. Current Oncology. 2022;29(5):3215-3223. https://doi.org/10.3390/curroncol29050261
  37. Alfano CM, Jefford M, Maher J, Birken SA, Mayer DK. Building personalized cancer follow-up care pathways in the United States: lessons learned from implementation in England, Northern Ireland, and Australia. Am Soc Clin Oncol Educ Book 2019;39:625-639. https://doi.org/10.1200/EDBK_238267
  38. Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. National Academies Press, Washington, DC, 2006.
  39. Nekhlyudov L, Ganz PA, Arora NK, Rowland JH. Going Beyond Being Lost in Transition: A Decade of Progress in Cancer Survivorship. J Clin Oncol. 2017 Jun 20;35(18):1978-1981. doi: 10.1200/JCO.2016.72.1373.
  40. Loonen JJ, Blijlevens NM, Prins J, Dona DJ, Den Hartogh J, Senden T, van Dulmen-Den Broeder E, van der Velden K, Hermens RP. Cancer Survivorship Care: Person Centered Care in a Multidisciplinary Shared Care Model. Int J Integr Care. 2018 Jan 16;18(1):4. doi: 10.5334/ijic.3046.
  41. McNeely ML, Binkley JM, Pusic AL, Campbell KL, Gabram S, Soballe PW. A prospective model of care for breast cancer rehabilitation: postoperative and post-reconstructive issues. Cancer. 2012 Apr 15;118(8 Suppl):2226-36. doi: 10.1002/cncr.27468.
  42. Howell D, Mayer DK, Fielding R, Eicher M, Verdonck-de Leeuw IM, Johansen C, et al. and Global Partners for Self-Management in Cancer. Management of Cancer and Health After the Clinic Visit: A Call to Action for Self-Management in Cancer Care. J Natl Cancer Inst. 2021 May 4;113(5):523-531. doi: 10.1093/jnci/djaa083.
  43. Vaz-Luis I, Masiero M, Cavaletti G, Cervantes A, Chlebowski RT, Curigliano G, et al. ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe. Ann Oncol. 2022 Nov;33(11):1119-1133. doi: 10.1016/j.annonc.2022.07.1941. Epub 2022 Aug 10. PMID: 35963481.
  44. Jefford M. Improving outcomes for cancer survivors. Cancer Forum 2009;33(3):159-163
  45. Howell D, Hack TF, Oliver TK, Chulak T, Mayo S, Aubin M, Chasen M, Earle CC, Friedman AJ, Green E, Jones GW, Jones JM, Parkinson M, Payeur N, Sabiston CM, Sinclair S. Survivorship services for adult cancer populations: a pan-Canadian guideline. Curr Oncol. 2011 Dec;18(6):e265-81. doi: 10.3747/co.v18i6.956. PMID: 22184494; PMCID: PMC3224035.
  46. Fitch M, Zomer S, Lockwood G, Louzado C, Shaw Moxam R, Rahal R, Green E. Experiences of adult cancer survivors in transitions. Support Care Cancer. 2019 Aug;27(8):2977-2986. doi: 10.1007/s00520-018-4605-3. Epub 2018 Dec 26. PMID: 30588549; PMCID: PMC6597588.
  47. Chan RJ, Crawford-Williams F, Crichton M, Joseph R, Hart NH, Milley K, Druce P, Zhang J, Jefford M, Lisy K, Emery J, Nekhlyudov L. Effectiveness and implementation of models of cancer survivorship care: an overview of systematic reviews. J Cancer Surviv. 2023 Feb;17(1):197-221. doi: 10.1007/s11764-021-01128-1.
  48. Langer G, Meerpohl JJ, Perleth M, Gartlehner G, Kaminski-Hartenthaler A, Schünemann H. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen. 2012;106(5):357-68.
  49. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-6. doi: 10.1136/bmj.39489.470347.AD.
  50. Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, Alderson P, Glasziou P, Falck-Ytter Y, Schünemann HJ. GRADE guidelines: 2. Framing the question and deciding on important outcomes. Journal of clinical epidemiology. 2011;64(4):395-400.
  51. Alonso-Coello P, Schünemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, Treweek S, Mustafa RA, Rada G, Rosenbaum S. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ. 2016;353.
  52. Alonso-Coello P, Oxman AD, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, Treweek S, Mustafa RA, Vandvik PO, Meerpohl J. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. Gaceta sanitaria. 2017;32(2):167. e1-. e10.
  53. Schünemann HJ, Mustafa R, Brozek J, Santesso N, Alonso-Coello P, Guyatt G, Scholten R, Langendam M, Leeflang MM, Akl EA. GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health. Journal of clinical epidemiology. 2016;76:89-98.
  54. Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S, Liberati A, O'Connell D, Oxman AD, Phillips B. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC health services research. 2004;4:1-7.
  55. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, Norris S, Falck-Ytter Y, Glasziou P, DeBeer H. GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables. Journal of clinical epidemiology. 2011;64(4):383-94.
  56. DistillerSR. Version 2.35. DistillerSR Inc.; 2021. Accessed [October 01, 2024]. https://www.distillersr.com/.
  57. Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available at www.covidence.org.
  58. Wang Y, Keitz S, Briel M, Glasziou P, Brignardello-Petersen R, Siemieniuk R A C et al. Development of ROBUST-RCT: Risk of Bias instrument for Use in Systematic reviews-for Randomized Controlled Trials  BMJ 2025; 388 :e081199 doi:10.1136/bmj-2024-081199
  59. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024. https://training.cochrane.org/handbook/current/chapter-06#section-6-5-2-2.
  60. Der Simonian R Fau - Laird N, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88.
  61. Cohen J. Statistical Power Analysis for the Behavioral Sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates, Publishers; 1988.
  62. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024. https://training.cochrane.org/handbook/current/chapter-10#section-10-10-2.
  63. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024 https://dataparty.ca/methods/detail/2.
  64. Hedges LV. Distribution theory for Glass's estimator of effect size and related estimators. Journal of Educational Statistics. 1981. https://doi.org/10.2307/1164588.
  65. Veronicki AA, Jackson D, Viechtbauer W, Bender R, Bowden J, Knapp G, Kuss O, Higgins JPT, Langan D, Salanti G. Methods to estimate the between-study variance and its uncertainty in meta-analysis. Research Synthesis Methods. 2014. https://doi.org/10.1002/jrsm.1164
  66. Jefford M, Chan RJ, Emery JD. Shared care is an appropriate model for many cancer survivors. J Clin Oncol. 2024 Jun 10;42(17):2105-2106. doi: 10.1200/JCO.23.02683. Epub 2024 Mar 18. PMID: 38498810.
  67. Vélez M, Wilson MG. Rapid synthesis: Enhancing shared-care models between primary-care and cancer-care teams in post-treatment care. Hamilton: McMaster Health Forum, 25 March 2021.
  68. Lisy K, Kent J, Dumbrell J, Kelly H, Piper A, Jefford M. Sharing Cancer Survivorship Care between Oncology and Primary Care Providers: A Qualitative Study of Health Care Professionals' Experiences. J Clin Med. 2020 Sep 16;9(9):2991. doi: 10.3390/jcm9092991.
  69. Lisy K, Kent J, Piper A, Jefford M. Facilitators and barriers to shared primary and specialist cancer care: a systematic review. Support Care Cancer. 2021 Jan;29(1):85-96. doi: 10.1007/s00520-020-05624-5.
  70. Alfano CM, Jefford M, Maher J, Birken SA, Mayer DK (2019) Building personalized cancer follow-up care pathways in the United States: lessons learned from implementation in England, Northern Ireland, and Australia. Am Soc Clin Oncol Educ Book 39:625–639. https://doi.org/10.1200/EDBK_238267
  71. Chan RJ, Crawford-Williams F, Crichton M. et al. Effectiveness and implementation of models of cancer survivorship care: an overview of systematic reviews. J Cancer Surviv. 2023;17:197–221 (2023). https://doi.org/10.1007/s11764-021-01128-1
  72. Shared care implementation in UK Innovation to Implementation: Stratified Pathways of Care for People Living with or beyond Cancer, A ‘How to Guide’. NHS Institute for Innovation and Improvement; London, UK: 2013. 
  73. Jefford M, Emery J. D., Martin A. J., Lourenco R. D. A., Lisy, K. Grunfeld, E. and Schofield, P. SCORE: a randomised controlled trial evaluating shared care (general practitioner and oncologist) follow-up compared to usual oncologist follow-up for survivors of colorectal cancer. eClinicalMedicine. 2023;66.
  74. Chan RJ, Agbejule OA, Yates PM, Emery J, Jefford M, Koczwara B, Hart NH, Crichton M, Nekhlyudov L. Outcomes of cancer survivorship education and training for primary care providers: a systematic review. J Cancer Surviv. 2022 Apr;16(2):279-302. doi: 10.1007/s11764-021-01018-6.
  75. Shapiro CL, Jacobsen PB, Henderson T, Hurria A, Nekhlyudov L, Ng A, Surbone A, Mayer DK, Rowland JH, Shapiro CL, Jacobsen PB, Henderson T, Hurria A, Nekhlyudov L, Ng A, Surbone A, Mayer DK, Rowland JH. ReCAP: ASCO Core Curriculum for Cancer Survivorship Education. J Oncol Pract. 2016 Feb;12(2):145, e108-17. doi: 10.1200/JOP.2015.009449.
  76. Crabtree BF, Miller WL, Howard J, Rubinstein EB, Tsui J, Hudson SV, O'Malley D, Ferrante JM, Stange KC. Cancer Survivorship Care Roles for Primary Care Physicians. Ann Fam Med. 2020 May;18(3):202-209. doi: 10.1370/afm.2498. PMID: 32393555; PMCID: PMC7213992.
  77. Jefford M, Koczwara B, Emery J, Thornton-Benko E, Vardy JL. The important role of general practice in the care of cancer survivors. Aust J Gen Pract. 2020;49(5):288-292.
  78. Love M, Debay M, Hudley AC, et al. Cancer Survivors, Oncology, and Primary Care Perspectives on Survivorship Care: An Integrative Review. Journal of Primary Care & Community Health. 2022;13. doi:10.1177/21501319221105248
  79. Vos JAM, Wieldraaijer T, van Weert HCPM, van Asselt KM. Survivorship care for cancer patients in primary versus secondary care: a systematic review. J Cancer Surviv. 2021 Feb;15(1):66-76. doi: 10.1007/s11764-020-00911-w. Epub 2020 Aug 19. PMID: 32815087; PMCID: PMC7822798.
  80. Tremblay D, Prady C, Bilodeau K, et al. Optimizing clinical and organizational practice in cancer survivor transitions between specialized oncology and primary care teams: a realist evaluation of multiple case studies. BMC Health Serv Res. 2017;17(1).
  81. Meiklejohn JA, Mimery A, Martin JH, et al. The role of the GP in follow-up cancer care: a systematic literature review. J Cancer Surviv. 2016;10(6):990-1011
  82. Mukherjee SD, Bainbridge D, Hillis C, Sussman J. Optimizing cancer survivorship care: examination of factors associated with transition to primary care. Curr. Oncology. 2023;30: 2743-2750. Doi.org/10.3390/curroncol30030207
  83. Grant M, De Rossi S, Sussman J. Supporting models to transition breast cancer survivors to primary care: formative evaluation of a Cancer Care Ontario initiative. J Oncol Practice. 2015;11(3):e288-e295.
  84. Sussman J, Beglaryan H, Payne A. et al. Follow-up model of care for cancer survivors: recommendations for the delivery of follow-up care for cancer survivors in Ontario. Cancer Care Ontario, March 2019. https://www.cancercareontario.ca/sites/ccocancercare/files/guidelines/full/FollowUpModelOfCareCancerSurvivors.pdf
  85. Mittmann N, Beglaryan H, Liu N, et al. Examination of health system resources and costs associated with transitioning cancer survivors to primary care: A propensity-score–matched cohort study. J Oncol Pract. 2018;14(11):e653-e664.
  86. Hayes BD, Young HG, Atrchian S, Vis-Dunbar M, Stork MJ, Pandher S, Samper S, McCorquodale S, Loader A, Voss C. Primary care provider-led cancer survivorship care in the first 5 years following initial cancer treatment: a scoping review of the barriers and solutions to implementation. J Cancer Surviv. 2024 Apr;18(2):352-365. doi: 10.1007/s11764-022-01268-y.
  87. Duong D, Vogel L. National survey highlights worsening primary care access. CMAJ. 2023 Apr 24;195(16):E592-E593. doi: 10.1503/cmaj.1096049.
  88. DeMaio P, Waddell K, Bain T, Alam S, Dass R, Cura J, Ali A, Bhuiya A, Wilson MG. Approaches to support transitions into and out of cancer care systems for patients who do not have a primary-care providers, McMaster Health Rapid Synthesis, 13 October 2023.
  89. Katerenchuk J, Salas AS. An integrative review on the oncology nurse navigator role in the Canadian context. Can Oncol Nurs J. 2023 Nov 1;33(4):385-399. doi: 10.5737/23688076334385.
  90. Canadian Association of Nurses in Oncology. (2020). Patient navigator in cancer care: A specialized oncology nurse role that contributes to high quality, person-centred care experiences and clinical efficiencies. https://cdn.ymaws.com/www.cano-acio.ca/resource/resmgr/position_statements/Patient_Navigation_2020_EN.pdf
  91. Chan RJ, Milch VE, Crawford-Williams F, Agbejule OA, Joseph R, Johal J, Dick N, Wallen MP, Ratcliffe J, Agarwal A, Nekhlyudov L, Tieu M, Al-Momani M, Turnbull S, Sathiaraj R, Keefe D, Hart NH. Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature. CA Cancer J Clin. 2023 Nov-Dec;73(6):565-589. doi: 10.3322/caac.21788.
  92. Halpern MT, Viswanathan M, Evans TS, Birken SA, Basch E, Mayer DK. Models of Cancer Survivorship Care: Overview and Summary of Current Evidence. J Oncol Pract. 2015 Jan;11(1):e19-27. doi: 10.1200/JOP.2014.001403. Epub 2014 Sep 9. PMID: 25205779.
  93. Hoeg BL, Bidstrup PE, Karlsen RV, et al. Follow-up strategies following completion of primary cancer treatment in adult cancer survivors. Cochrane Database Syst Rev 2019; 11.
  94. Thom B, Boekhout AH, Corcoran S, Adsuar R, Oeffinger KC, McCabe MS. Advanced practice providers and survivorship care: they can deliver. J Oncolo Pract. 2019;Mar15(3):e230-237. Doi: 10.1200/JOP.18.00359
  95. Ross. N. APRN-led clinics enable comprehensive survivorship care. ONS Voice. https://voice.ons.org/news-and-views/aprn-led-clinics-enable-comprehensive-survivorship-care. 2018. Accessed Oct 28, 2024.
  96. Chan L, Dewart G. A call for nurse practitioner-led cancer survivorship clinics: The need for development and adoption within Ontario, Canada. Canadian Oncology Nursing Journal / Revue canadienne de soins infirmiers en oncologie, [S.l.], 2023;33(2):260-268, Apr. 2023. ISSN 2368-8076
  97. Warkentin L, Moga C, Sajida S. Institute of Health Economics. Patient initiated follow-up in ambulatory car: rapid review. Edmonton (AB): Institute of Health Economics, 2024.
  98. Whear R, Thompson‐Coon J, Rogers M, et al. Patient‐initiated appointment systems for adults with chronic conditions in secondary care. Cochrane Database Syst Rev. 2020;4(4):CD010763
  99. Dretzke J, Chaudri T, Balaji R, Mehanna H, Nankivell P, Moore DJ; PETNECK2 Research Team. A systematic review of the effectiveness of patient-initiated follow-up after cancer. Cancer Med. 2023 Sep;12(18):19057-19071. doi: 10.1002/cam4.6462.
  100. National Health Service (NHS). Personalized Care 10-year plan. https://www.longtermplan.nhs.uk
  101. Maher J, Petchey L, Greenfield D, Levitt G, Fraser M. Implementation of nationwide cancer survivorship plans: Experience from the UK, J of Cancer Policy. 2018;15(Part B):76-81, ISSN 2213-5383, https://doi.org/10.1016/j.jcpo.2018.01.002.
  102. Kantilal K, Hardeman W, Whiteside H, Karapanadagioutou E, Small M, Bhaddacharya D. Facilitating health care practitioners to deliver self-management support in adult cancer survivors: a realist review. Research in Social and Admin. Pharmacy. 2022;18(11):3870-3883. Doi.org/10.1016/j.sapharm.2022.05.011.
  103. Howell D, Mayer DK, Fielding R, Eicher M, Verdonck-de Leeuw IM, et al. Global Partners for Self-Management in Cancer. Management of Cancer and Health After the Clinic Visit: A Call to Action for Self-Management in Cancer Care. J Natl Cancer Inst. 2021 May 4;113(5):523-531. doi: 10.1093/jnci/djaa083.
  104. Peters DH, Adam T, Alonge O, et al Republished research: Implementation research: what it is and how to do it. British Journal of Sports Medicine 2014;48:731-736.
  105. Mitchell SA, Chambers DA. Leveraging Implementation Science to Improve Cancer Care Delivery and Patient Outcomes. J Oncol Pract. 2017 Aug;13(8):523-529. doi: 10.1200/JOP.2017.024729.
  106. Leeman, J., Birken, S., Powell, B.J. et al. Beyond “implementation strategies”: classifying the full range of strategies used in implementation science and practice. Implementation Sci 12, 125 (2017). https://doi.org/10.1186/s13012-017-0657-x
  107. LaGrandeur W, Armin J, Howe CL et al. Survivorship care plan outcomes for primary care physicians, cancer survivors, and systems: A scoping review. J Cancer Surviv 2018;12:334–34
  108. Hill RE, Wakefield CE, Cohn RJ, Fardell JE, Brierley ME, Kothe E, Jacobsen PB, Hetherington K, Mercieca‐Bebber R. Survivorship Care Plans in Cancer: A Meta‐Analysis and Systematic Review of Care Plan Outcomes, The Oncologist 2020;25(2): e351–e372, https://doi.org/10.1634/theoncologist.2019-0184
  109. Halpern MT, Viswanathan M, Evans TS, Birken SA, Basch E, Mayer DK. Models of Cancer Survivorship Care: Overview and Summary of Current Evidence. J Oncol Pract. 2015 Jan;11(1):e19-27. doi: 10.1200/JOP.2014.001403.
  110. Biddell CB, Spees LP, Mayer DK, Wheeler SB, Trogdon JG, Rotter J, Birken SA. Developing personalized survivorship care pathways in the United States: Existing resources and remaining challenges. Cancer. 2021 Apr 1;127(7):997-1004. doi: 10.1002/cncr.33355.
  111. Vardy JL, Chan JR, Koczwara B, Lisy K, Cohn RJ, Joske D, Dhillon HM, Jefford M. Clinical Oncology Society of Australia position statement on cancer survivorship care. AJGP 2019;48(12):833-842.
  112. Implementing personalized stratified follow-up pathways: a handbook for local health and care systems. March 2020. https://www.england.nhs.uk/wp-content/uploads/2020/04/cancer-stratified-follow-up-handbook-v1-march-2020.pdf
  113. Urquhart R, Cordoba W, Bender J, Cuthbert C, Easley J, Howell D, Kaal J, Kendell C, Radford S, Sussman J. Risk Stratification and Cancer Follow-Up: Towards More Personalized Post-Treatment Care in Canada. Current Oncology. 2022; 29(5):3215-3223. https://doi.org/10.3390/curroncol29050261
  114. Cancer Disparities Progress Report.org (Internet). Philadelphia: American Association for Cancer Research. Copyrighted. Available from http:///www.CancerDispartiesProgress Report.org/Disparities in cancer survivorship care. Accessed January 10, 2025
  115. Gifford W, Larocque C, Dick P. Culturally Safe Cancer Care for Indigenous People: Nursing Practice Beyond the Rhetoric. Clin J Oncol Nurs. 2022 Jul 25;26(4):443-448. doi: 10.1188/22.CJON.443-448.
  116. Gifford W, Thomas R, Barton G, Graham ID. Providing culturally safe cancer survivorship care with Indigenous communities: study protocol for an integrated knowledge translation study. Pilot Feasibility Stud. 2019 Feb 26;5:33. doi: 10.1186/s40814-019-0422-9.
  117. Gifford W, Dick P, Larocque C, Modanloo S, Wazni L, Awar ZA, Benoit M. What culturally safe cancer care means to Algonquins of Pikwakanagan First Nation. AlterNative: An International Journal of Indigenous Peoples. 2023 19(2), 387-397. https://doi.org/10.1177/11771801231168681 

References